Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Sell
42
PTBRY Quote, Financials, Valuation and Earnings
Last price:
$13.62
Seasonality move
:
-0.02%
Day range:
$13.60 - $14.28
52-week range:
$10.59 - $16.07
Dividend yield:
8.12%
P/E ratio:
8.36x
P/S ratio:
1.86x
P/B ratio:
0.99x
Volume:
1.5K
Avg. volume:
756
1-year change:
-1.58%
Market cap:
$10.1B
Revenue:
$5.4B
EPS (TTM):
$1.63
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $4.8B | $5B | $5.3B | $5.3B | $5.4B | |
| Revenue Growth (YoY) | -4.23% | 4.74% | 6.16% | -0.11% | 1.66% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $138.6M | $90.8M | -- | -- | -- | |
| Operating Expenses | -$843.1M | -$1.5B | -$1.6B | -$1.6B | -$1.4B | |
| Operating Income | $843.1M | $1.5B | $1.6B | $1.6B | $1.4B | |
| Net Interest Expenses | $92.3M | $152.5M | $244M | $303.5M | $279.8M | |
| EBT. Incl. Unusual Items | $828M | $1.5B | $1.7B | $1.7B | $1.5B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $109.9M | $284M | $296.8M | $308.7M | $258.7M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | $5.5M | $11.5M | $12.9M | $13M | $4.2M | |
| Net Income to Common Excl Extra Items | $766.8M | $1.2B | $1.4B | $1.4B | $1.2B | |
| Basic EPS (Cont. Ops) | $0.51 | $1.66 | $1.84 | $1.81 | $1.62 | |
| Diluted EPS (Cont. Ops) | $0.51 | $1.66 | $1.84 | $1.81 | $1.62 | |
| Weighted Average Basic Share | $745M | $745.5M | $745.1M | $745.8M | $745.9M | |
| Weighted Average Diluted Share | $745M | $745.5M | $745.1M | $745.8M | $745.9M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $1.7B | $2.4B | $3B | $3.3B | $3.2B | |
| Revenue (Reported) | $4.8B | $5B | $5.3B | $5.3B | $5.4B | |
| Operating Income (Reported) | $843.1M | $1.5B | $1.6B | $1.6B | $1.4B | |
| Operating Income (Adjusted) | $1.7B | $2.4B | $3B | $3.3B | $3.2B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.2B | $1.3B | $1.3B | $1.5B | $1.5B | |
| Revenue Growth (YoY) | -7.13% | 5.73% | 1.95% | 10.45% | -1.66% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $6M | $379.9K | -- | -- | -- | |
| Operating Expenses | -$194.2M | -$365.7M | -$376.6M | -$396.9M | -$325.8M | |
| Operating Income | $194.2M | $365.7M | $376.6M | $396.9M | $325.8M | |
| Net Interest Expenses | $28.2M | $70.3M | $60.8M | $89.8M | $61.9M | |
| EBT. Incl. Unusual Items | $186.9M | $379.1M | $401.6M | $425.1M | $357.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$20.4M | $78.5M | $67.1M | $93.6M | $64.8M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | $3.7M | $3.9M | $3.9M | $5.1M | -$2.7M | |
| Net Income to Common Excl Extra Items | $225.4M | $300.6M | $334.5M | $331.4M | $293.1M | |
| Basic EPS (Cont. Ops) | $0.15 | $0.40 | $0.44 | $0.44 | $0.40 | |
| Diluted EPS (Cont. Ops) | $0.15 | $0.40 | $0.44 | $0.44 | $0.40 | |
| Weighted Average Basic Share | $745M | $745.9M | $745.1M | $745.1M | $745.1M | |
| Weighted Average Diluted Share | $745M | $745.9M | $745.1M | $745.1M | $745.1M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $394.8M | $653.2M | $729.4M | $849.5M | $787M | |
| Revenue (Reported) | $1.2B | $1.3B | $1.3B | $1.5B | $1.5B | |
| Operating Income (Reported) | $194.2M | $365.7M | $376.6M | $396.9M | $325.8M | |
| Operating Income (Adjusted) | $394.8M | $653.2M | $729.4M | $849.5M | $787M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $4.8B | $5B | $5.4B | $5.6B | $5.5B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $138.3M | $92.9M | -- | -- | -- | |
| Operating Expenses | -$845.3M | -$1.5B | -$1.6B | -$1.6B | -$1.4B | |
| Operating Income | $845.3M | $1.5B | $1.6B | $1.6B | $1.4B | |
| Net Interest Expenses | $92.6M | $149.9M | $245M | $305.1M | $281M | |
| EBT. Incl. Unusual Items | $830.2M | $1.5B | $1.7B | $1.7B | $1.5B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $110M | $282.2M | $298.1M | $311.1M | $259.7M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | $5.5M | $11.3M | $12.9M | $13M | $4.3M | |
| Net Income to Common Excl Extra Items | $769M | $1.2B | $1.4B | $1.4B | $1.2B | |
| Basic EPS (Cont. Ops) | $0.51 | $1.21 | $1.61 | $1.82 | $1.63 | |
| Diluted EPS (Cont. Ops) | $0.51 | $1.21 | $1.61 | $1.82 | $1.63 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $1.7B | $2.4B | $3B | $3.3B | $3.2B | |
| Revenue (Reported) | $4.8B | $5B | $5.4B | $5.6B | $5.5B | |
| Operating Income (Reported) | $845.3M | $1.5B | $1.6B | $1.6B | $1.4B | |
| Operating Income (Adjusted) | $1.7B | $2.4B | $3B | $3.3B | $3.2B | |
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $5B | $5.4B | $5.6B | $5.5B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $92.9M | $42.1M | -- | -- | -- | |
| Operating Expenses | -$1.5B | -$1.6B | -$1.6B | -$1.4B | -- | |
| Operating Income | $1.5B | $1.6B | $1.6B | $1.4B | -- | |
| Net Interest Expenses | $149.9M | $245M | $305.1M | $281M | -- | |
| EBT. Incl. Unusual Items | $1.5B | $1.7B | $1.7B | $1.5B | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $282.2M | $298.1M | $311.1M | $259.7M | -- | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | $11.3M | $12.9M | $13M | $4.3M | -- | |
| Net Income to Common Excl Extra Items | $1.2B | $1.4B | $1.4B | $1.2B | -- | |
| Basic EPS (Cont. Ops) | $1.21 | $1.61 | $1.82 | $1.63 | -- | |
| Diluted EPS (Cont. Ops) | $1.21 | $1.61 | $1.82 | $1.63 | -- | |
| Weighted Average Basic Share | $3B | $3.7B | $3B | $3B | -- | |
| Weighted Average Diluted Share | $3B | $3.7B | $3B | $3B | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $2.4B | $3B | $3.3B | $3.2B | -- | |
| Revenue (Reported) | $5B | $5.4B | $5.6B | $5.5B | -- | |
| Operating Income (Reported) | $1.5B | $1.6B | $1.6B | $1.4B | -- | |
| Operating Income (Adjusted) | $2.4B | $3B | $3.3B | $3.2B | -- | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $10.7B | $9.4B | $7.5B | $4.7B | $7.3B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $290.3M | $248.8M | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $17.6B | $15.2B | $14.3B | $9.6B | $12.8B | |
| Property Plant And Equipment | $1.9B | $1.7B | $1.8B | $1.9B | $1.9B | |
| Long-Term Investments | $2B | $2B | $2B | $1.7B | $2B | |
| Goodwill | -- | $46.6M | -- | -- | -- | |
| Other Intangibles | -- | $1.6M | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $67.9B | $66.4B | $70.5B | $70.3B | $81.7B | |
| Accounts Payable | $8.9M | $16.4M | $48.9M | $12.8M | $60.7M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $38.7B | $38.7B | $40.3B | $41.1B | $46.4B | |
| Long-Term Debt | $2.6B | $3B | $2.7B | $1.4B | $3.2B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $59B | $57.3B | $60.4B | $60B | $71.1B | |
| Common Stock | $637.1M | $583.5M | $587.2M | $563.5M | $543M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $4.4B | $8.8B | $9.7B | $10.1B | $10.3B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $195.7M | $282.4M | $298.4M | $278.6M | $276.4M | |
| Total Equity | $8.9B | $9B | $10B | $10.4B | $10.6B | |
| Total Liabilities and Equity | $67.9B | $66.4B | $70.5B | $70.3B | $81.7B | |
| Cash and Short Terms | $12.2B | $10.5B | -- | -- | -- | |
| Total Debt | $2.6B | $3B | $2.7B | $1.5B | $3.2B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $10.7B | $9.4B | $7.5B | $4.7B | $7.3B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $290.3M | $248.8M | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $17.6B | $15.2B | $14.3B | $9.6B | $12.8B | |
| Property Plant And Equipment | $1.9B | $1.7B | $1.8B | $1.9B | $1.9B | |
| Long-Term Investments | $2B | $2B | $2B | $1.7B | $2B | |
| Goodwill | -- | $46.6M | -- | -- | -- | |
| Other Intangibles | -- | $1.6M | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $67.9B | $66.4B | $70.5B | $70.3B | $81.7B | |
| Accounts Payable | $8.9M | $16.4M | $48.9M | $12.8M | $60.7M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $38.7B | $38.7B | $40.3B | $41.1B | $46.4B | |
| Long-Term Debt | $2.6B | $3B | $2.7B | $1.4B | $3.2B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $59B | $57.3B | $60.4B | $60B | $71.1B | |
| Common Stock | $637.1M | $583.5M | $587.2M | $563.5M | $543M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $195.7M | $282.4M | $298.4M | $278.6M | $276.4M | |
| Total Equity | $8.9B | $9B | $10B | $10.4B | $10.6B | |
| Total Liabilities and Equity | $67.9B | $66.4B | $70.5B | $70.3B | $81.7B | |
| Cash and Short Terms | $12.2B | $10.5B | -- | -- | -- | |
| Total Debt | $2.6B | $3B | $2.7B | $1.5B | $3.2B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $2.3B | $3.2B | $2.4B | $2.3B | $1.5B | |
| Capital Expenditures | $129.3M | $164.9M | $154.2M | $195.8M | $175.9M | |
| Cash Acquisitions | -- | $270.1M | $52.4M | -- | -- | |
| Cash From Investing | -$2.5B | -$6.2B | -$5B | -$7.1B | -$10.7B | |
| Dividends Paid (Ex Special Dividend) | $57.3M | $184M | $479.5M | $658.8M | $841.9M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1.2B | $1.3B | -- | -- | -- | |
| Long-Term Debt Repaid | -$985.6M | -$937.6M | -- | -- | -- | |
| Repurchase of Common Stock | $8.9M | -- | $11.8M | -- | -- | |
| Other Financing Activities | -$37.7M | $70.2M | -- | -- | -- | |
| Cash From Financing | $6.2B | $2.4B | $1.9B | $1.2B | $12.1B | |
| Beginning Cash (CF) | $8.8B | $11.7B | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $8.6B | -$574.3M | -$696.9M | -$3.6B | $3B | |
| Ending Cash (CF) | $12.1B | $11B | -- | -- | -- | |
| Levered Free Cash Flow | $2.2B | $3B | $2.3B | $2.1B | $1.4B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $562.2M | $884.8M | $810.4M | $1B | $424.5M | |
| Capital Expenditures | -$17.7M | -$75.5M | $32.1M | $109.8M | $112.1M | |
| Cash Acquisitions | -- | -$2.5M | $52.7M | -- | -- | |
| Cash From Investing | -$1B | -$6.7B | -$2.4B | -$4B | -$7.2B | |
| Dividends Paid (Ex Special Dividend) | $636.2K | -$2M | -$2.2M | $9.7M | -$2.4M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -$151.4M | -$109M | -- | -- | -- | |
| Long-Term Debt Repaid | -$397.7M | $30.1M | -- | -- | -- | |
| Repurchase of Common Stock | $99.3K | -- | -$54K | -- | -- | |
| Other Financing Activities | -$70.6M | -$44.1M | -- | -- | -- | |
| Cash From Financing | $3B | $5.6B | $4.3B | $3.4B | $5.8B | |
| Beginning Cash (CF) | $9.7B | $7.4B | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -$17.3M | $4.2M | -$604.4K | -$8.8M | -$42.5M | |
| Additions / Reductions | $2.5B | -$236.9M | $2.7B | $401.1M | -$1B | |
| Ending Cash (CF) | $12.1B | $11B | -- | -- | -- | |
| Levered Free Cash Flow | $579.9M | $960.4M | $778.3M | $935.4M | $312.4M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $2.3B | $3.1B | $2.4B | $2.3B | $1.5B | |
| Capital Expenditures | $129.6M | $100.4M | $155M | $196.3M | $176.8M | |
| Cash Acquisitions | -- | $236.1M | $52.7M | -- | -- | |
| Cash From Investing | -$2.5B | -$6.2B | -$5.1B | -$7.1B | -$10.7B | |
| Dividends Paid (Ex Special Dividend) | $57.4M | $183.8M | $482.1M | $660.8M | $846.1M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1.2B | $1.3B | -- | -- | -- | |
| Long-Term Debt Repaid | -$985.6M | -$937.6M | -- | -- | -- | |
| Repurchase of Common Stock | $9M | -- | $11.8M | -- | -- | |
| Other Financing Activities | -$37.7M | $70.2M | -- | -- | -- | |
| Cash From Financing | $6.2B | $2.4B | $1.9B | $1.2B | $12.2B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $8.7B | -$636.7M | -$700.7M | -$3.6B | $3B | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $2.2B | $3B | $2.3B | $2.1B | $1.4B | |
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $3.1B | $2.4B | $2.3B | $1.5B | -- | |
| Capital Expenditures | $100.4M | $155M | $196.3M | $176.8M | -- | |
| Cash Acquisitions | $236.1M | $52.7M | -- | -- | -- | |
| Cash From Investing | -$6.2B | -$5.1B | -$7.1B | -$10.7B | -- | |
| Dividends Paid (Ex Special Dividend) | $183.8M | $482.1M | $660.8M | $846.1M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $1.3B | $444.3M | -- | -- | -- | |
| Long-Term Debt Repaid | -$937.6M | -$846.5M | -- | -- | -- | |
| Repurchase of Common Stock | -- | $11.8M | -- | -- | -- | |
| Other Financing Activities | $70.2M | $205.8M | -- | -- | -- | |
| Cash From Financing | $2.4B | $1.9B | $1.2B | $12.2B | -- | |
| Beginning Cash (CF) | $34.9B | $21.2B | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | $7.8M | -$9.9M | -$2.2M | -$8M | -- | |
| Additions / Reductions | -$636.7M | -$700.7M | -$3.6B | $3B | -- | |
| Ending Cash (CF) | $33.9B | $20.5B | -- | -- | -- | |
| Levered Free Cash Flow | $3B | $2.3B | $2.1B | $1.4B | -- | |
Get PTBRY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
PTBRY
Sector
P/E ratio
8.36x
--
PEG ratio
0.27x
--
P/B ratio
0.99x
--
Price / LTM sales
1.86x
--
Growth Metrics
PTBRY
Sector
Revenue growth
-1.66%
--
Earnings growth
-9.38%
--
Revenue (5-year growth)
1.58%
--
Earnings forecast
--
--
Profitability
PTBRY
Sector
Profitability FY 2025
--
--
Return on invested capital
7.43%
--
Return on assets
1.64%
--
Return on equity
11.75%
--
Earnings Date
Last Earnings Date
Feb
3
Next Earnings Date
Apr
27
Estimated Next Earnings Date
May
5
Balance Sheet
PTBRY
Sector
Total cash
--
--
Short term investments
--
--
Total assets
$81.7B
--
Long term debt
$3.2B
--
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
51
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 34x
Sell
44
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Buy
77
CPS alert for Feb 14
Cooper-Standard Holdings, Inc. [CPS] is up 32.06% over the past day.
Buy
58
TPH alert for Feb 14
Tri Pointe Homes, Inc. [TPH] is up 26.83% over the past day.
Sell
20
IRON alert for Feb 14
Disc Medicine, Inc. [IRON] is down 21.88% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
